Emodin induces apoptosis of human cervical cancer hela cells via intrinsic mitochondrial and extrinsic death receptor pathway

Cancer Cell International

Volumn 13, Issue 1, 2013, Pages

  Yaoxian, Wang ^a,b   Hui, Yu ^a   Yunyan, Zhang ^a   Yanqin, Liu ^a   Xin, Ge ^c   Xiaoke, Wu ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b HEILONGJIANG UNIVERSITY   (China)

^c Department of General Surgery   (China)

Author keywords

Apoptosis; Emodin; Flow cytometry; HeLa cells; Tunel

Indexed keywords

ANNEXIN; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 3; CASPASE 8; CASPASE 9; DEATH RECEPTOR; EMODIN; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; HOE 33342; MESSENGER RNA; PROCASPASE 3; PROCASPASE 8; PROCASPASE 9;

APOPTOSIS; ARTICLE; CANCER CELL; CELL VIABILITY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; NICK END LABELING; REAL TIME POLYMERASE CHAIN REACTION; UTERINE CERVIX CANCER;

EID: 84880090627     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-13-71     Document Type: Article

References (52)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001, 2:533-543. 10.1016/S1470-2045(01)00486-7, 11905707.
2. World Health Organization. Comprehensive cervical cancer control: A guide to essential practice 2006, Geneva: WHO, World Health Organization.
3. Fujimoto J. Novel strategy of anti-angiogenic therapy for uterine cervical carcinomas. Anticancer Res 2009, 29:2665-2669.
4. Ma YS, Weng SW, Lin MW, et al. Antitumor effects of emodin on LS1034 human colon cancer cells in vitro and in vivo: Roles of apoptotic cell death and LS1034 tumor xenografts model. Food Chem Toxicol 2012, 50:1271-1278. 10.1016/j.fct.2012.01.033, 22321733.
5. Wang HH, Chung JG. Emodin-induced inhibition of growth and DNA damage in the Helicobacter pylori. Curr Microbiol 1997, 35:262-266. 10.1007/s002849900250, 9462956.
6. Chang CH, Lin CC, Yang JJ, et al. Anti-inflammatory effects of emodin from ventilago leiocarpa. Am J Chin Med 1996, 24:139-142. 10.1142/S0192415X96000189, 8874670.
7. Huang HC, Chang JH, Tung SF, et al. Immunosuppressive effect of emodin, a free radical generator. Eur J Pharmacol 1992, 211:359-364. 10.1016/0014-2999(92)90393-I, 1535596.
8. Jing X, Ueki N, Cheng J, et al. Induction of apoptosis in hepatocellular carcinoma cell lines by emodin. Jpn J Cancer Res 2002, 93:874-882. 10.1111/j.1349-7006.2002.tb01332.x, 12716464.
9. Lai JM, Chang JT, Wen CL, et al. Emodin induces a reactive oxygen species-dependent and ATM-p53-Bax mediated cytotoxicity in lung cancer cells. Eur J Pharmacol 2009, 623:1-9. 10.1016/j.ejphar.2009.08.031, 19744477.
10. Chun-Guang W, Jun-Qing Y, Bei-Zhong L, et al. Anti-tumor activity of emodin against human chronic myelocytic leukemia K562 cell lines in vitro and in vivo. Eur J Pharmacol 2010, 627:33-41. 10.1016/j.ejphar.2009.10.035, 19857484.
11. Hsu CM, Hsu YA, Tsai Y, et al. Emodin inhibits the growth of hepatoma cells: finding the common anti-cancer pathway using Huh7, Hep3B, and HepG2 cells. Biochem Biophys Res Commun 2010, 392:473-478. 10.1016/j.bbrc.2009.10.153, 19895793.
12. Lin SY, Lai WW, Ho CC, et al. Emodin induces apoptosis of human tongue squamous cancer SCC-4 cells through reactive oxygen species and mitochondria-dependent pathways. Anticancer Res 2009, 29:327-336.
13. Cai J, Niu X, Chen YY, et al. Emodin-induced generation of reactive oxygen species inhibits RhoA activation to sensitize gastric carcinoma cells to anoikis. Neoplasia 2008, 10:41-45. 10.1593/neo.07754, 2213898, 18231637.
14. Cha TL, Qiu L, Chen CT, et al. Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth. Cancer Res 2005, 65:2287-2295. 10.1158/0008-5472.CAN-04-3250, 15781642.
15. Wang W, Sun YP, Huang XZ, et al. Emodin enhances sensitivity of gallbladder cancer cells to platinum drugs via glutathion depletion and MRP1 downregulation. Biochem Pharmacol 2010, 79:1134-1140. 10.1016/j.bcp.2009.12.006, 20005210.
16. Shi YQ, Fukai T, Sakagami H, et al. Cytotoxic and DNA damage-inducing activities of low molecular weight phenols from rhubarb. Anticancer Res 2001, 21:2847-2853.
17. Chan TC, Chang CJ, Koonchanok NM, et al. Selective inhibition of the growth of ras-transformed human bronchial epithelial cells by emodin, a protein-tyrosine kinase inhibitor. Biochem Biophys Res Commun 1993, 193:1152-1158. 10.1006/bbrc.1993.1746, 7686746.
18. Srinivas G, Anto RJ, Srinivas P, et al. Emodin induces apoptosis of human cervical cancer cells through poly (ADP-ribose) polymerase cleavage and activation of caspase-9. Eur J Pharmacol 2003, 473:117-125. 10.1016/S0014-2999(03)01976-9, 12892828.
19. Wang XD, Gu LQ, Wu JY. Apoptosis-inducing activity of new pyrazole emodin derivatives in human hepatocellular carcinoma HepG2 cells. Biol Pharm Bull 2007, 30:1113-1116. 10.1248/bpb.30.1113, 17541163.
20. Lee HZ, Hsu SL, Liu MC, et al. Effects and mechanisms of aloe-emodin on cell death in human lung squamous cell carcinoma. Eur J Pharmacol 2001, 431:287-295. 10.1016/S0014-2999(01)01467-4, 11730720.
21. Shieh DE, Chen YY, Yen MH, et al. Emodin-induced apoptosis through p53-dependent pathway in human hepatoma cells. Life Sci 2004, 74:2279-2290. 10.1016/j.lfs.2003.09.060, 14987952.
22. Qu K, Shen NY, Xu XS, et al. Emodin induces human T cell apoptosis in vitro by ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction. Acta Pharmacol Sin 2013, Epub ahead of print.
23. Su YT, Chang HL, Shyue SK, et al. Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species-dependent mitochondrial signaling pathway. Biochem Pharmacol 2005, 70:229-241. 10.1016/j.bcp.2005.04.026, 15941563.
24. Huang Q, Shen HM, Ong CN. Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-kappaB. Biochem Pharmacol 2004, 68:361-371. 10.1016/j.bcp.2004.03.032, 15194008.
25. Yang J, Li H, Chen YY, et al. Anthraquinones sensitize tumor cells to arsenic cytotoxicity in vitro and in vivo via reactive oxygen species-mediated dual regulation of apoptosis. Free Radic Biol Med 2004, 37:2027-2041. 10.1016/j.freeradbiomed.2004.09.016, 15544921.
26. Olsen BB, Bjorling-Poulsen M, Guerra B. Emodin negatively affects the phosphoinositide 3-kinase/AKT signaling pathway: a study on its mechanism of action. Int J Biochem Cell Biol 2007, 39:227-237. 10.1016/j.biocel.2006.08.006, 17018259.
27. Lee HZ. Protein kinase C involvement in aloe-emodin and emodin-induced apoptosis in lung carcinoma cell. Br J Pharmacol 2001, 134:1093-1103. 10.1038/sj.bjp.0704342, 1573035, 11682458.
28. Malhi H, Gores GJ. Cellular and molecular mechanisms of liver injury. Gastroenterology 2008, 134:1641-1654. 10.1053/j.gastro.2008.03.002, 2553363, 18471544.
29. Muppidi J, Porter M, Siegel RM. Measurement of apoptosis and other forms of cell death. Curr Protoc Immunol 2004, 3:3-17.
30. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001, 411:342-348. 10.1038/35077213, 11357141.
31. Kaulmann SH, Earnshaw WC. Induction of apoptosis by cancer chemotherapy. Exp Cell Res 2000, 256:42-49. 10.1006/excr.2000.4838, 10739650.
32. MacKenzie SH, Clark AC. Targeting cell death in tumors by activating caspases. Curr Cancer Drug Targets 2008, 8:98-109. 10.2174/156800908783769391, 3119715, 18336192.
33. Repicky A, Jantova S, Milata V. Signal pathways of cell proliferation and death as targets of potential chemotherapeutics. Ceska Slov Farm 2008, 57:4-10.
34. Slee EA, Harte MT, Kluck RM, et al. Ordering the Cytochrome c-initiated Caspase Cascade: Hierarchical Activation of Caspases-2, -3, -6, -7, -8, and -10 in a Caspase-9-dependent Manner. J Cell Biol 1999, 144:281-292. 10.1083/jcb.144.2.281, 2132895, 9922454.
35. Lee HJ, Lee HJ, Lee EO, et al. Mitochondria-cytochrome c-caspase-9 cascade mediates isorhamnetin-induced apoptosis. Cancer Lett 2008, 270:342-353. 10.1016/j.canlet.2008.05.040, 18617322.
36. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998, 281:1312-1316.
37. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993, 74:609-619. 10.1016/0092-8674(93)90509-O, 8358790.
38. Sedlak TW, Oltvai ZN, Yang E, et al. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc Natl Acad Sci USA 1995, 92:7834-7838. 10.1073/pnas.92.17.7834, 41240, 7644501.
39. Mantena SK, Baliga MS, Katiyar SK. Grape seed proanthocyanidins induce apoptosis and inhibit metastasis of highly metastatic breast carcinoma cells. Carcinogenesis 2006, 27:1682-1691.
40. Heo SK, Yun HJ, Park WH, et al. Emodin inhibits TNF-alpha-induced human aortic smooth-muscle cell proliferation via caspase- and mitochondrial-dependent apoptosis. J Cell Biochem 2008, 105:70-80. 10.1002/jcb.21805, 18494000.
41. Chen H, Wei W, Guo Y, et al. Enhanced effect of gemcitabine by emodin against pancreatic cancer in vivo via cytochrome Cregulated apoptosis. Oncol Rep 2011, 25:1253-1261.
42. Mullauer L, Mosberger I, Grusch M, et al. Fas ligand is expressed in normal breast epithelial cells and is frequently up regulated in breast cancer. J Pathol 2000, 190:20-30. 10.1002/(SICI)1096-9896(200001)190:1<20::AID-PATH497>3.0.CO;2-S, 10640988.
43. Fukuzawa K, Takahashi K, Furuta K, et al. Expression of Fas/Fas Ligand and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC). J Gastroenterol 2001, 36:681-688. 10.1007/s005350170031, 11686478.
44. Shimoyama M, Kanda T, Liu L, et al. Expression of Fas ligand is an early event in colorectal carcinogenesis. J Surg Oncol 2001, 76:63-68. 10.1002/1096-9098(200101)76:1<63::AID-JSO1011>3.0.CO;2-C, 11223827.
45. Abdulkarim B, Sabri S, Deutsh E, et al. Radiation-induced expression of functional Fas ligand in EBV-positive human nasopharyngeal carcinoma cells. Int J Cancer 2000, 86:229-237. 10.1002/(SICI)1097-0215(20000415)86:2<229::AID-IJC12>3.0.CO;2-1, 10738250.
46. Krammer PH, Arnold R, Lavrik IN. Life and death in peripheral T cells. Nat Rev Immunol 2007, 7:532-542. 10.1038/nri2115, 17589543.
47. Kischkel FC, Hellbardt S, Behrmann I, et al. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 1995, 14:5579-5588. 394672, 8521815.
48. Ashkenazi A. Targeting the extrinsic apoptosis pathway in cancer. Cytokine Growth Factor Rev 2008, 19:325-331. 10.1016/j.cytogfr.2008.04.001, 18495520.
49. Golks A, Brenner D, Fritsch C, et al. c-FLIPR, a new regulator of death receptor-induced apoptosis. J Biol Chem 2005, 280:14507-14513. 10.1074/jbc.M414425200, 15701649.
50. Sprick MR, Rieser E, Stahl H, et al. Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but cannot functionally substitute caspase-8. EMBO J 2002, 21:4520-4530. 10.1093/emboj/cdf441, 126181, 12198154.
51. Muzio M, Chinnaiyan AM, et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996, 85:817-827. 10.1016/S0092-8674(00)81266-0, 8681377.
52. Chang DW, Xing Z, Capacio VL, et al. Interdimer processing mechanism of procaspase-8 activation. EMBO J 2003, 22:4132-4142. 10.1093/emboj/cdg414, 175803, 12912912.